LEXEO THERAPEUTICS, INC.

Other languages Lexeo Therapeutics, Inc.

Equities

LXEO

US52886X1072

Market Closed - Nasdaq Other stock markets 01:30:00 25/05/2024 am IST			5-day change	1st Jan Change
15.46 ^USD	-0.13%		+11.62%	+15.20%

09/05	Lexeo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/05	Certain Options of Lexeo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lexeo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Lexeo Therapeutics, Inc. Announces Not to Stand for Reelection of Bernard Davitian as Director	22/04
Lexeo Therapeutics, Inc. Announces the U.S. Food and Drug Administration Grants Fast Track Designation for LX2006, an Aav-Based Gene Therapy Candidate for the Treatment of Friedreich?s Ataxia Cardiomyopathy	16/04
Lexeo Therapeutics' Q4 Net Loss Narrows; Cash Runway Extended to 2027 -- Shares Jump Pre-Bell	11/03
LEXEO: ENTERED INTO COMMON STOCK PURCHASE AGREEMENT TO…	11/03
Lexeo Therapeutics Promotes Sandi See Tai to Chief Development Officer, Makes Other Appointments	06/02
Lexeo Therapeutics, Inc. Strengthens Clinical Development Leadership with New Executive Appointments	05/02
Top Premarket Decliners	13/12
Lexeo Therapeutics Insider Bought Shares Worth $2,499,992, According to a Recent SEC Filing	10/11
Lexeo Therapeutics Insider Bought Shares Worth $4,999,995, According to a Recent SEC Filing	10/11
Lexeo Therapeutics Insider Bought Shares Worth $4,999,995, According to a Recent SEC Filing	10/11
Lexeo Therapeutics, Inc. has completed an IPO in the amount of $100.00001 million.	02/11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer